Yahoo
NasdaqGS - Nasdaq Real Time Price USD

United Therapeutics Corporation (UTHR)

582.46 +20.44 (+3.64%)
At close: November 9 at 4:00:00 PM EST
581.25 -1.21 (-0.21%)
Overnight: 2:43:41 AM EST
Trade UTHR on Coinbase
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements have been upgraded
A new layout with more detail in every statement.
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Cash Flow from Operating Activities, Indirect
1,429,600 1,561,200 1,327,100 978,000 802,500
Cash Flow from Investing Activities
93,000 -551,300 417,200 -719,600 -811,500
Cash Flow from Financing Activities
-1,673,800 -1,150,000 -1,254,800 -11,900 75,400
Cash and Cash Equivalents, End of Period
1,188,900 1,557,100 1,697,200 1,207,700 961,200
Cash Flow, Supplemental
Free Cash Flow to Firm
1,170,313.84 1,156,890.50 1,110,162 826,661 829,848
Capital Expenditure, Calculated
562,400 526,000 246,500 230,400 138,800
Issuance of Capital Stock
0 0 0 0 0
Repurchase of Capital Stock
-2,055,200 -1,016,600 -1,012,200 -13,800 -11,400
Free Cash Flow to Cash Flow from Operating Activities
0.67 0.68 0.81 0.77 0.85
12/31/2022 - 6/17/1999

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: